118 related articles for article (PubMed ID: 27071702)
21. Peroxisome proliferator-activated receptor alpha agonist-induced down-regulation of hepatic glucocorticoid receptor expression in SD rats.
Chen X; Li M; Sun W; Bi Y; Cai M; Liang H; Yu Q; He X; Weng J
Biochem Biophys Res Commun; 2008 Apr; 368(4):865-70. PubMed ID: 18267115
[TBL] [Abstract][Full Text] [Related]
22. Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats.
Mohamed DI; Elmelegy AA; El-Aziz LF; Abdel Kawy HS; El-Samad AA; El-Kharashi OA
Eur J Pharmacol; 2013 Dec; 721(1-3):35-42. PubMed ID: 24140572
[TBL] [Abstract][Full Text] [Related]
23. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M
J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal.
El Kebbaj Z; Andreoletti P; Mountassif D; Kabine M; Schohn H; Dauça M; Latruffe N; El Kebbaj MS; Cherkaoui-Malki M
Endocrinology; 2009 Mar; 150(3):1192-201. PubMed ID: 18948393
[TBL] [Abstract][Full Text] [Related]
25. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver.
Kersten S; Stienstra R
Biochimie; 2017 May; 136():75-84. PubMed ID: 28077274
[TBL] [Abstract][Full Text] [Related]
26. PPARα activation protects against cholestatic liver injury.
Zhao Q; Yang R; Wang J; Hu DD; Li F
Sci Rep; 2017 Aug; 7(1):9967. PubMed ID: 28855630
[TBL] [Abstract][Full Text] [Related]
27. Dietary fenofibrate reduces hepatic lipid deposition by regulating lipid metabolism in yellow catfish Pelteobagrus fulvidraco exposed to waterborne Zn.
Zheng JL; Luo Z; Hu W; Pan YX; Zhuo MQ
Lipids; 2015 Apr; 50(4):417-26. PubMed ID: 25757601
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the actions of peroxisome proliferator-activated receptor alpha on obesity by estrogen.
Jeong S; Yoon M
Obesity (Silver Spring); 2007 Jun; 15(6):1430-40. PubMed ID: 17557980
[TBL] [Abstract][Full Text] [Related]
29. Potential involvement of PPAR α activation in diminishing the hepatoprotective effect of fenofibrate in NAFLD: Accuracy of non- invasive panel in determining the stage of liver fibrosis in rats.
Hamed AM; El-Kharashi OA; Boctor SS; Abd-Elaziz LF
Biomed Pharmacother; 2017 Jan; 85():68-78. PubMed ID: 27930988
[TBL] [Abstract][Full Text] [Related]
30. 5-Caffeoylquinic acid decreases diet-induced obesity in rats by modulating PPARα and LXRα transcription.
Huang K; Liang XC; Zhong YL; He WY; Wang Z
J Sci Food Agric; 2015 Jul; 95(9):1903-10. PubMed ID: 25186103
[TBL] [Abstract][Full Text] [Related]
31. [The hepatotoxic action of pyrazinamide and its effect on lipid peroxidation].
Slivka IuI
Probl Tuberk; 1988; (10):47-50. PubMed ID: 3231608
[No Abstract] [Full Text] [Related]
32. Terminalia chebula (fruit) prevents liver toxicity caused by sub-chronic administration of rifampicin, isoniazid and pyrazinamide in combination.
Tasduq SA; Singh K; Satti NK; Gupta DK; Suri KA; Johri RK
Hum Exp Toxicol; 2006 Mar; 25(3):111-8. PubMed ID: 16634329
[TBL] [Abstract][Full Text] [Related]
33. Kaempferol regulates the lipid-profile in high-fat diet-fed rats through an increase in hepatic PPARα levels.
Chang CJ; Tzeng TF; Liou SS; Chang YS; Liu IM
Planta Med; 2011 Nov; 77(17):1876-82. PubMed ID: 21728151
[TBL] [Abstract][Full Text] [Related]
34. Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4.
Sanguino E; Roglans N; Alegret M; Sánchez RM; Vázquez-Carrera M; Laguna JC
Br J Pharmacol; 2005 Aug; 145(7):853-61. PubMed ID: 15912134
[TBL] [Abstract][Full Text] [Related]
35. Fenofibrate prevents orotic acid--induced hepatic steatosis in rats.
Ferreira AV; Parreira GG; Porto LC; Mario EG; Delpuerto HL; Martins AS; Botion LM
Life Sci; 2008 Apr; 82(15-16):876-83. PubMed ID: 18374364
[TBL] [Abstract][Full Text] [Related]
36. Astragalus polysaccharides repress myocardial lipotoxicity in a PPARalpha-dependent manner in vitro and in vivo in mice.
Chen W; Lai Y; Wang L; Xia Y; Chen W; Zhao X; Yu M; Li Y; Zhang Y; Ye H
J Diabetes Complications; 2015 Mar; 29(2):164-75. PubMed ID: 25499591
[TBL] [Abstract][Full Text] [Related]
37. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
[TBL] [Abstract][Full Text] [Related]
38. Isoniazid and its toxic metabolite hydrazine induce in vitro pyrazinamide toxicity.
Tostmann A; Boeree MJ; Peters WH; Roelofs HM; Aarnoutse RE; van der Ven AJ; Dekhuijzen PN
Int J Antimicrob Agents; 2008 Jun; 31(6):577-80. PubMed ID: 18358703
[TBL] [Abstract][Full Text] [Related]
39. Age-related decrease in expression of peroxisome proliferator-activated receptor alpha and its effects on development of dyslipidemia.
Ye P; Wang ZJ; Zhang XJ; Zhao YL
Chin Med J (Engl); 2005 Jul; 118(13):1093-8. PubMed ID: 16098262
[TBL] [Abstract][Full Text] [Related]
40. Assessment of hepatotoxicity of first-line anti-tuberculosis drugs on Wistar rats.
Sharma R; Kaur R; Mukesh M; Sharma VL
Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):83-93. PubMed ID: 29124333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
